Ascent enhances the value of therapeutic products by establishing pathways that make the optimal integration of Japan and China into global drug development possible.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
N/A - Ascent provides CRO services
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):